These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 34313353)

  • 21. Circular RNA circ-CMPK1 contributes to cell proliferation of non-small cell lung cancer by elevating cyclin D1 via sponging miR-302e.
    Cui D; Qian R; Li Y
    Mol Genet Genomic Med; 2020 Feb; 8(2):e999. PubMed ID: 31863641
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MicroRNA-103a-3p Promotes Cell Proliferation and Invasion in Non-Small-Cell Lung Cancer Cells through Akt Pathway by Targeting PTEN.
    Li H; Huhe M; Lou J
    Biomed Res Int; 2021; 2021():7590976. PubMed ID: 34307670
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CircRNA_101237 promotes NSCLC progression via the miRNA-490-3p/MAPK1 axis.
    Zhang ZY; Gao XH; Ma MY; Zhao CL; Zhang YL; Guo SS
    Sci Rep; 2020 Jun; 10(1):9024. PubMed ID: 32494004
    [TBL] [Abstract][Full Text] [Related]  

  • 24. LncRNA SNHG16 promotes non-small cell lung cancer development through regulating EphA2 expression by sponging miR-520a-3p.
    Yu L; Chen D; Song J
    Thorac Cancer; 2020 Mar; 11(3):603-611. PubMed ID: 31953899
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Circular RNA hsa_circ_0000317 inhibits non-small cell lung cancer progression through regulating microRNA-494-3p/phosphatase and tensin homolog deleted on chromosome 10 axis.
    Xia S; Zhang Z
    Clinics (Sao Paulo); 2022; 77():100086. PubMed ID: 35917658
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Circular RNA circVAPA contributes to non-small-cell lung cancer progression via miR-342-3p-dependent regulation of ZEB2.
    Liu X; Cheng Y; Wang Y; Zhang Y
    World J Surg Oncol; 2021 Nov; 19(1):335. PubMed ID: 34839824
    [TBL] [Abstract][Full Text] [Related]  

  • 27. LncRNA PCGEM1 accelerates non-small cell lung cancer progression via sponging miR-433-3p to upregulate WTAP.
    Weng L; Qiu K; Gao W; Shi C; Shu F
    BMC Pulm Med; 2020 Aug; 20(1):213. PubMed ID: 32787827
    [TBL] [Abstract][Full Text] [Related]  

  • 28. LncRNA CCDC144NL-AS1 Serves as a Prognosis Biomarker for Non-small Cell Lung Cancer and Promotes Cellular Function by Targeting miR-490-3p.
    Zhang L; Chi B; Chai J; Qin L; Zhang G; Hua P; Jin C
    Mol Biotechnol; 2021 Oct; 63(10):933-940. PubMed ID: 34115289
    [TBL] [Abstract][Full Text] [Related]  

  • 29. circRNA hsa_circ_0005909 Predicts Poor Prognosis and Promotes the Growth, Metastasis, and Drug Resistance of Non-Small-Cell Lung Cancer via the miRNA-338-3p/SOX4 Pathway.
    Song HM; Meng D; Wang JP; Zhang XY
    Dis Markers; 2021; 2021():8388512. PubMed ID: 34413915
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Circular RNA hsa_circ_0014130 Inhibits Apoptosis in Non-Small Cell Lung Cancer by Sponging miR-136-5p and Upregulating BCL2.
    Geng Y; Bao Y; Zhang W; Deng L; Su D; Zheng H
    Mol Cancer Res; 2020 May; 18(5):748-756. PubMed ID: 32060230
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis.
    Lu C; Shan Z; Hong J; Yang L
    Int J Oncol; 2017 Jul; 51(1):235-244. PubMed ID: 28534966
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CircRNA_102179 promotes the proliferation, migration and invasion in non-small cell lung cancer cells by regulating miR-330-5p/HMGB3 axis.
    Zhou ZF; Wei Z; Yao JC; Liu SY; Wang F; Wang Z; Chen XF; Lin H; Ye Y; Zheng QF
    Pathol Res Pract; 2020 Nov; 216(11):153144. PubMed ID: 32911346
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Circular RNA circ_0020123 promotes non-small cell lung cancer progression by acting as a ceRNA for miR-488-3p to regulate ADAM9 expression.
    Wan J; Hao L; Zheng X; Li Z
    Biochem Biophys Res Commun; 2019 Jul; 515(2):303-309. PubMed ID: 31153639
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Circular RNA hsa_circ_0072309 inhibits non-small cell lung cancer progression by sponging miR-580-3p.
    Pang W; Huang F; Zhang X; Ye M; Huang Y; Huang X; Pang J; Cai C; Wang Z
    Biosci Rep; 2020 May; 40(5):. PubMed ID: 32293004
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Up-regulated circular RNA VANGL1 contributes to progression of non-small cell lung cancer through inhibition of miR-195 and activation of Bcl-2.
    Wang L; Ma H; Kong W; Liu B; Zhang X
    Biosci Rep; 2019 Jun; 39(6):. PubMed ID: 31076544
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Downregulation of hsa_circ_0007580 inhibits non-small cell lung cancer tumorigenesis by reducing miR-545-3p sponging.
    Chen S; Lu S; Yao Y; Chen J; Yang G; Tu L; Zhang Z; Zhang J; Chen L
    Aging (Albany NY); 2020 Jul; 12(14):14329-14340. PubMed ID: 32681720
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MiR-141-3p functions as a tumor suppressor through directly targeting ZFR in non-small cell lung cancer.
    Li W; Cui Y; Wang D; Wang Y; Wang L
    Biochem Biophys Res Commun; 2019 Feb; 509(3):647-656. PubMed ID: 30611568
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MiR-323-3p Targeting Transmembrane Protein with EGF-Like and 2 Follistatin Domain (TMEFF2) Inhibits Human Lung Cancer A549 Cell Apoptosis by Regulation of AKT and ERK Signaling Pathways.
    Fan JM; Zheng ZR; Zeng YM; Chen XY
    Med Sci Monit; 2020 Feb; 26():e919454. PubMed ID: 32009129
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Circular RNA HIPK3 induces cell proliferation and inhibits apoptosis in non-small cell lung cancer through sponging miR-149.
    Lu H; Han X; Ren J; Ren K; Li Z; Sun Z
    Cancer Biol Ther; 2020; 21(2):113-121. PubMed ID: 31597523
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CircRNA High Mobility Group At-hook 2 regulates cell proliferation, metastasis and glycolytic metabolism of nonsmall cell lung cancer by targeting miR-331-3p to upregulate High Mobility Group At-hook 2.
    Li S; Zhao J; Wen S; Li M; Yu F; Wang W; Shao H; Jiang D
    Anticancer Drugs; 2023 Jan; 34(1):81-91. PubMed ID: 36066399
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.